flibanserin
sprout pharmaceuticals,spdr s&p biotech,ishares biotechnology
['flibanserin', 'sprout', 'breast', 'sprout ', '$ibb', '$xbi']
sprout pharmaceuticals reveals positive interim results for flibanserin in breast cancer patients with low libido, to be presented at 2023 asco annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt